The purpose of this study was to assess the in-use stability of the UNISTRAIN® PRRS vaccine after it has been reconstituted with ERYSENG® PARVO in comparison with the in-use stability of another European commercial PRRS MLV reconstituted with the SE and PPV vaccine from the same manufacturer.